Insys Therapeutics

Showing 4 posts of 4 posts found.

800px-fentanyl_patch_packages

Insys Therapeutics founder John Kapoor found guilty of bribing doctors

May 3, 2019
Medical Communications Insys Therapeutics, John Kapoor, Subsys, fentanyl, opioid crisis, opioids, pharma

The founder of opioid drugmaker Insys Therapeutics has been found guilty of bribing doctors in order to persuade them to …

andrew_long

Insys Therapeutics names current CFO Andrew Long as company’s new CEO

April 17, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insys Therapeutics, appointment, pharma

Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s new CEO. The opioid drugmaker …

andrew_long

Insys Therapeutics names current CFO Andrew Long as company’s new CEO

April 16, 2019
Manufacturing and Production CEO, Insys Therapeutics, Subsys, appointments, cfo, pharma

Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s new CEO. The opioid drugmaker …

shutterstock_4030507

Insys Therapeutics sees revenue from Subsys at $61-$62 million; shares plunge 21%

April 11, 2016
Business Services, Manufacturing and Production, Sales and Marketing Insys Therapeutics, Stock Price, Subsys, opioids, pain drug

Insys Therapeutics Inc (Nasdaq: INSY) stock plunged nearly 21% Monday after the company said sales for its pain drug will …

The Gateway to Local Adoption Series

Latest content